Sign in

NCT07256704Recruiting

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Hypnosis and Attention in Patients With a Neurological Disease

Source: ClinicalTrials.gov · Last updated 14 Aug 2026

Brief summary (registry, in English)

This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
48 (estimated)
First submitted
20 Nov 2025
Start date
18 Nov 2025
Primary completion date
31 Jul 2029
Lead sponsor
Luzerner Kantonsspital
NCT number
NCT07256704

What you commit to

  • Study type: Interventional
  • Planned participants: 48
  • From 18 Nov 2025 to the primary completion date, 31 Jul 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Psychiatric disease
  • \- Scalp or skin conditions that interfere with EEG electrode placement (e.g. open wounds, infections, severe psoriasis) Implanted medical or neurostimulation devices that interfere with EEG electrode placement (e.g. deep brain stimulators, cochlear implants)

Who the study is looking for

  • ICD-10 Diagnosis of stroke, TBI or MS
  • Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation
  • Age 18 years old or older
  • Understanding the German language
  • Written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Luzerner Kantonsspital
Coordinator of this site? Confirm its status
LucerneSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.